NIH-funded research Fellowship grant

Investigating gene regulation linked to schizophrenia using advanced CRISPR techniques

Official title: Understanding gene regulation in schizophrenia-associated loci using high-throughput epigenetic CRISPR screens

Funded at Duke University · NIH-10993269 · Data updated 2026-11-12

This study is looking at how certain genes might play a role in schizophrenia, using a special tool called CRISPR to explore these genetic factors, and the findings could help develop new treatments for people living with this condition.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionDuke University
NIH-funded
Lab location1 site (Durham, United States)
Project startJuly 11, 2024
Project endJuly 10, 2027
Funding year2024
Award (this year)$42,519
NIH project number1F31MH138142-01
Project IDNIH-10993269 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with schizophrenia or those with a family history of the disorder.

Less likely to help

Patients without a diagnosis of schizophrenia or those not genetically predisposed to the condition may not benefit from this research.

What this research studies

This research focuses on understanding the genetic factors that contribute to schizophrenia by using high-throughput CRISPR screens. The approach involves identifying non-coding genetic variants associated with schizophrenia and determining how they regulate gene expression. By employing CRISPR-Cas9 technology, researchers aim to dissect these variants at a large scale, linking them to their target genes and enhancing our understanding of the genetic basis of this complex disorder. Patients may benefit from insights gained that could lead to new therapeutic strategies.

Why it matters

Potential benefit: If successful, this research could lead to improved understanding and treatment options for individuals with schizophrenia.

How similar studies have gone: Other research utilizing CRISPR technology has shown promise in understanding genetic disorders, suggesting that this approach could yield valuable insights into schizophrenia as well.

Where this research is happening

  • Duke University
    Durham, United States
    Active

Researchers

  • Principal investigator: Hamilton, Marisa C. — Duke University
  • Study coordinator: Hamilton, Marisa C.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.